Amicus Therapeutics, Inc.
USD14.49
+0.00 (+0.00%)
CEO
Bradley L. Campbell
IPO Date
2007-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.49
Prev. Close
$14.49
Day Low
$14.49
Day High
$14.49
52W Low
$5.51
52W High
$14.50
Market Cap
$4.55B
| -51.1 |
| 31 Dec 2023 | FY | 90.7% | -38.0% | -94.6% | -19.5% | 2.78 | 2.88 | -27.6 |
| 31 Dec 2022 | FY | 88.3% | -71.9% | -192.3% | -32.7% | 3.67 | 3.05 | -14.9 |
| 31 Dec 2021 | FY | 88.7% | -82.0% | -81.5% | -27.7% | 1.43 | 4.09 | -12.5 |
| 31 Dec 2020 | FY | 88.1% | -106.1% | -96.7% | -31.2% | 1.54 | 4.47 | -21.6 |
| 31 Dec 2019 | FY | 87.9% | -195.6% | -74.8% | -41.9% | 0.44 | 4.04 | -6.6 |
| 31 Dec 2018 | FY | 84.2% | -382.5% | -101.8% | -44.2% | 0.94 | 6.40 | -5.1 |
| 31 Dec 2017 | FY | 83.1% | -769.0% | -80.5% | -45.3% | 0.47 | 5.60 | -7.8 |
| 31 Dec 2016 | FY | 83.2% | -4034.7% | -55.5% | -19.3% | 0.43 | 3.06 | -3.3 |
| 35.1 |
| 30 Jun 2025 | Q2 | 90.2% | -15.8% | -12.0% | -3.0% | 2.17 | 3.21 | -18.1 |
| 31 Mar 2025 | Q1 | 90.7% | -17.3% | -11.2% | -2.7% | 2.29 | 3.34 | -28.9 |
| 31 Dec 2024 | Q4 | 90.1% | 9.8% | 7.6% | 1.9% | 2.29 | 3.39 | 47.8 |
| 30 Sept 2024 | Q3 | 90.6% | -4.8% | -3.8% | -0.9% | 2.49 | 3.15 | -120.9 |
| 30 Jun 2024 | Q2 | 91.1% | -12.4% | -11.8% | -2.1% | 3.35 | 2.75 | -47.4 |
| 31 Mar 2024 | Q1 | 87.7% | -43.9% | -37.0% | -6.7% | 3.40 | 3.03 | -18.4 |
| 31 Dec 2023 | Q4 | 90.2% | -29.4% | -21.1% | -4.4% | 2.78 | 2.88 | -30.8 |
| 30 Sept 2023 | Q3 | 90.4% | -20.8% | -16.2% | -2.8% | 3.41 | 2.73 | -41.7 |